Suchergebnisse - "López-Medina, Eduardo"

PubPharm (5)

1

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age : A Phase 1/2 Randomized Trial

enthalten in: The Journal of infectious diseases | 2024

von Sáez-Llorens, X. | Norero, X. | Mussi-Pinhata, M. | +38

2

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age : A phase 2 randomized, double-blind trial

enthalten in: Human vaccines & immunotherapeutics | 2023

von López, P. | López-Medina, E. | Sáez-Llorens, X. | +6

3

Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years : a randomised, controlled, phase 2, non-inferiority study

enthalten in: The Lancet. Infectious diseases | 2022

von Coronel-Martinez, D. | Park, J. | López-Medina, E. | +14

CommentIn: Lancet Infect Dis. 2022 Jun;22(6):756-757. - PMID 35364020

4

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

enthalten in: Lancet (London, England) | 2022

von Bravo, L. | Smolenov, I. | Han, H. | +44

CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704

5

Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65) : a randomised, controlled, phase 2, non-inferiority study

enthalten in: The Lancet. Infectious diseases | 2021

von Coronel-MartÍnez, D. | Park, J. | López-Medina, E. | +17

1
[1]